Home> Products 
Flibanserin powder cas 167933-07-5, sold under the brand name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD).
Product introduction：
Product name: Flibanserin
Cas: 167933-07-5
Assay: ≥99.0%
MF: C20H21F3N4O
Molecular Weight: 390.4
Description: Flibanserin powder cas 167933-07-5, sold under the brand name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD). The medication increases the number of satisfying sexual events per month by about one half over placebo from a starting point of about two to three.
Specification:
|
Product Name |
Flibanserin |
CAS No. |
167933-07-5 |
|
Batch No. |
202003001 |
Mfg. Date |
20200326 |
|
Quantity |
10KG |
Quality Standard |
Enterprise Standard |
|
Tests |
SPECIFICATIONS |
RESULTS |
|
|
Appearance |
White crystalline powder |
White crystalline powder |
|
|
Melting point |
128℃~132℃ |
129℃~131℃ |
|
|
Identification |
1 |
UV identification |
Conforms |
|
2 |
IR identification |
Conforms |
|
|
3 |
fluoride identification |
Conforms |
|
|
Related substances |
Total impurities ≤0.5% |
0.11% |
|
| Max unknown single impurity ≤0.1% |
0.079% |
||
|
fluorine |
14.5%～16.4% |
15.07% |
|
|
Loss on drying |
≤1.0% |
0.10% |
|
|
Residue on ignition |
≤0.1% |
0.05% |
|
|
Heavy metal |
≤10ppm |
Conforms |
|
|
Remaining solvent |
Acetone≤0.5% |
0.009% |
|
| Isopropanol≤0.5% |
N.D. |
||
|
Assay |
≥99.0% |
99.95 |
|
|
Conclusion |
The results conform to the Enterprise standard |
||
← Nortadalafil Powder CAS 171596-36-4 | Raw Orlistat Powder CAS 96829-58-2 →
